company background image
MERK logo

Merck IDX:MERK Stock Report

Last Price

Rp3.87k

Market Cap

Rp1.7t

7D

0.5%

1Y

-16.2%

Updated

23 Jun, 2024

Data

Company Financials

MERK Stock Overview

Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.

MERK fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends3/6

PT Merck Tbk Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Merck
Historical stock prices
Current Share PriceRp3,870.00
52 Week HighRp5,100.00
52 Week LowRp3,830.00
Beta0.63
11 Month Change-3.73%
3 Month Change-0.51%
1 Year Change-16.23%
33 Year Change16.22%
5 Year Change-2.76%
Change since IPO1,294.60%

Recent News & Updates

Recent updates

Shareholder Returns

MERKID PharmaceuticalsID Market
7D0.5%0.1%2.0%
1Y-16.2%-22.7%1.0%

Return vs Industry: MERK exceeded the ID Pharmaceuticals industry which returned -22.7% over the past year.

Return vs Market: MERK underperformed the ID Market which returned 1% over the past year.

Price Volatility

Is MERK's price volatile compared to industry and market?
MERK volatility
MERK Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement5.8%
10% most volatile stocks in ID Market13.0%
10% least volatile stocks in ID Market2.7%

Stable Share Price: MERK has not had significant price volatility in the past 3 months.

Volatility Over Time: MERK's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1970381Evie Yulinwww.merckgroup.com/id-id

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines.

PT Merck Tbk Fundamentals Summary

How do Merck's earnings and revenue compare to its market cap?
MERK fundamental statistics
Market capRp1.73t
Earnings (TTM)Rp155.58b
Revenue (TTM)Rp949.80b

11.1x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MERK income statement (TTM)
RevenueRp949.80b
Cost of RevenueRp577.95b
Gross ProfitRp371.85b
Other ExpensesRp216.26b
EarningsRp155.58b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)347.29
Gross Margin39.15%
Net Profit Margin16.38%
Debt/Equity Ratio0%

How did MERK perform over the long term?

See historical performance and comparison

Dividends

8.3%

Current Dividend Yield

92%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.